Information about the rules and regulations that govern interactions between pharmaceutical, bioscience, medical device company, and other life sciences company interactions with physicians and other healthcare professionals. This includes information on the Sunshine Act, state laws, the PhRMA Code, and the AdvaMed Code on Ethical Interactions with Healthcare Professionals.
Seventy-three percent of off-label recommendations for 160 commonly prescribed drugs were made with little or no scientific evidence to support their use. That's one of the conclusions in “Off-label Prescribing Among Office-based Physicians,”...
“Pharma is under a lot of government and public scrutiny. This industry also runs on meetings. You put those two facts together, and you can see that a meeting can expose pharma to significant risk of enforcement activity if not done correctly,”...
While talking with various CME industry stakeholders about peer review of CME content during the past months, I observed a lack of consistency in the definition of the term, employment of a process, and reasons for using or not using reviews...
When the Office of Inspector General issued its pharma marketing guidance in 2003, some experts predicted that drug companies would initially curtail their excesses, and after a while the feds would ease up and the pendulum would swing back to the...
Having toiled in the vineyards of CME for most of my long career, I am all too familiar with the views of those who find little to like about our CME system, particularly the commercial support process. Charges of bias, promotion disguised as...
There are many gray areas when it comes to applying the Accreditation Council for CME's updated Standards for Commercial Support to meeting planning. That was the focus of the closed-door industry exchange for medical education and communication...
I had high expectations going into the hot-topics session about the ongoing Senate investigation into pharmaceutical companies' educational grants at the Alliance for CME annual conference — but I left disappointed and concerned about the CME...
You may leave your heart in San Francisco — but if you give a pen to a doctor there, you'd better keep track of how much it cost — or so says the new California Marketing Compliance Law (CMCL). What is this new law? Whom does it affect? Why should...
“Receiving a letter from the United States Senate Finance Committee is a frightening experience,” said a CME professional from a major pharmaceutical company during a hot-topics session at the Alliance for CME annual conference. From the comments...
